Loading...

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

Published
20 Aug 24
Updated
22 Oct 25
AnalystConsensusTarget's Fair Value
US$167.81
2.3% overvalued intrinsic discount
22 Oct
US$171.60
Loading
1Y
35.7%
7D
13.3%

Author's Valuation

US$167.812.3% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on22 Oct 25
Fair value Increased 3.07%

3M's fair value estimate has increased by $5.00 to $167.81 as analysts cite modest operating outperformance and positive momentum from new product initiatives, despite some lingering concerns. Analyst Commentary Recent updates from Street research highlight diverging analyst sentiment regarding 3M's valuation trajectory and execution on strategic initiatives.

Shared on08 Oct 25
Fair value Increased 0.73%

Narrative Update: 3M Analyst Price Target Revision Analysts have increased their price target for 3M to $162.81 from $161.63, citing improved full-year guidance prospects and renewed interest as a short-term buy idea. Analyst Commentary Recent commentary from Street research highlights both optimistic and cautious stances regarding 3M’s near-term prospects.

Shared on07 May 25
Fair value Increased 8.80%

Shared on30 Apr 25
Fair value Decreased 0.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 2.63%

AnalystConsensusTarget has increased revenue growth from 1.5% to 1.7%.

Shared on16 Apr 25
Fair value Increased 1.97%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 3.51%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.06%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.039%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 2.16%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 6.12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.